entity,start_date,end_date,context,AARSRAPPORT_html,AARSRAPPORT_pdf,AARSRAPPORT_xml,AddressOfAuditorCountry,AddressOfAuditorDistrictName,AddressOfAuditorPostCodeIdentifier,AddressOfAuditorStreetBuildingIdentifier,AddressOfAuditorStreetName,AddressOfReportingEntityDistrictName,AddressOfReportingEntityPostCodeIdentifier,AddressOfReportingEntityStreetBuildingIdentifier,AddressOfReportingEntityStreetName,AddressOfSubmittingEnterprisePostcodeAndTown,AddressOfSubmittingEnterpriseStreetAndNumber,AddresseeOfAuditorsReportOnAuditedFinancialStatements,ClassOfReportingEntity,ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement,ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults,DateOfApprovalOfAnnualReport,DateOfApprovalOfReport,DateOfFoundationOfReportingEntity,DateOfGeneralMeeting,DescriptionOfAnyUncertaintyConnectedWithRecognitionOrMeasurement,DescriptionOfAnyUnusualMattersAffectingRecognitionOrMeasurement,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfAdministrativeExpenses,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCashAndCashEquivalents,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeAssets,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfInvestmentProperty,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfOtherOperatingIncomeAndExpenses,DescriptionOfQualificationsOfAuditedFinancialStatements,DescriptionOfSignificantEventsOccurringAfterEndOfReportingPeriod,DisclosureOfDeferredTaxAssetsAndLiabilities,DisclosureOfDepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss,DisclosureOfOtherOperatingExpenses,DisclosureOfTaxExpenseOnOrdinaryActivities,Equity,ExplanationOfNotDisclosingCashFlowsStatements,ExplanationOfPrepayments,FaxNumberOfReportingEntity,HomepageOfReportingEntity,IdentificationNumberCvrOfAuditFirm,IdentificationNumberCvrOfReportingEntity,IdentificationNumberCvrOfSubmittingEnterprise,IdentificationOfApprovedAnnualReport,IncreaseDecreaseOfIntangibleAssetsThroughTransfers,InformationOnRemunerationOfManagementCategoriesAndSpecialIncentiveProgrammes,InformationOnReportingClassOfEntity,InformationOnSegments,InformationOnTypeOfSubmittedReport,ManagementsStatementAboutManagementsReview,NameAndSurnameOfChairmanOfGeneralMeeting,NameAndSurnameOfMemberOfExecutiveBoard,NameOfAuditFirm,NameOfReportingEntity,NameOfSubmittingEnterprise,PlaceOfSignatureOfStatement,PrecedingReportingPeriodStartDate,PredingReportingPeriodEndDate,RecommendationForApprovalOfAnnualReportByGeneralMeeting,RegisteredOfficeOfReportingEntity,ReportingPeriodEndDate,ReportingPeriodStartDate,RetrospectiveInformationOnContributedCapital,SignatureOfAuditorsDate,SignatureOfAuditorsPlace,TelephoneNumberOfAuditor,TelephoneNumberOfReportingEntity,TitleOfMemberOfSupervisoryBoard,TransferImpairmentLossesAndAmortisationOfIntangibleAssets,TypeOfAuditorAssistance,_id,_index,_score,cvrNummer,indlaesningsId,indlaesningsTidspunkt,offentliggoerelsesTidspunkt,offentliggoerelsestype,omgoerelse,regNummer,regnskabsperiode_slutDato,regnskabsperiode_startDato,sagsNummer,sidstOpdateret,ProvisionsForDeferredTax,ProfitLoss,FeesForAuditorsPerformingStatutoryAudit,AdjustmentsForCurrentTaxOfPriorPeriod,AdjustmentsForDeferredTax,AdministrativeExpenses,AmortisationOfIntangibleAssets,AverageNumberOfEmployees,CostOfProduction,DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss,DepreciationOfPropertyPlantAndEquipment,EmployeeBenefitsExpense,EquityRatio,ExchangeRateAdjustmentsOtherFinanceExpenses,ExchangeRateLoss,ExchangeRateProfit,GrossMargin,GrossResult,ImpairmentLossesOfPropertyPlantAndEquipment,InterestExpenseAssignedToGroupEnterprises,InterestSubsidyForTaxOnAccount,InvestmentInPropertyPlantAndEquipment,OperatingMargin,OtherAdjustmentsOfFinanceExpenses,OtherAdjustmentsOfFinanceIncome,OtherFinanceExpenses,OtherFinanceIncome,OtherOperatingExpenses,OtherOperatingIncome,PostemploymentBenefitExpense,ProfitLossFromOrdinaryActivitiesBeforeTax,ProfitLossFromOrdinaryOperatingActivities,RefundInJointAssessment,RemunerationOfManagementCategories,ResultsFromNetFinancials,ReturnOnCapitalEmployed,ReturnOnEquity,Revenue,SocialSecurityContributions,TaxExpense,TaxExpenseOnOrdinaryActivities,WagesAndSalaries,NominalValueOfIssuedShares,DeferredTaxLiability,AcquiredIntangibleAssets,Assets,CashAndCashEquivalents,ContributedCapital,CurrentAssets,DeferredIncomeAssets,FixturesFittingsToolsAndEquipment,IntangibleAssets,LandAndBuildings,LeaseholdImprovements,LiabilitiesAndEquity,LiabilitiesOtherThanProvisions,NoncurrentAssets,OtherShorttermPayables,OtherShorttermReceivables,PropertyPlantAndEquipment,PropertyPlantAndEquipmentInProgress,Provisions,RetainedEarnings,ShorttermLiabilitiesOtherThanProvisions,ShorttermPayablesToGroupEnterprises,ShorttermReceivables,ShorttermReceivablesFromGroupEnterprises,ShorttermTaxPayables,ShorttermTaxReceivables,ShorttermTradePayables,AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets,IntangibleAssetsGross,AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment,PropertyPlantAndEquipmentGross,DescriptionOfAuditor,NameAndSurnameOfAuditor,AdditionsToPropertyPlantAndEquipment,DisposalsOfPropertyPlantAndEquipment,ImpairmentLossesAndDepreciationOfDisposedPropertyPlantAndEquipment,IncreaseDecreaseOfPropertyPlantAndEquipmentThroughTransfers,TransferImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment,NameAndSurnameOfMemberOfSupervisoryBoard,DescriptionOfClassOfIssuedShares
26060702,2015-01-01,2015-01-01,c309,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",390000.0,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2015-01-01,2015-01-01,c354,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",3612951000.0,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2015-01-01,2015-01-01,c8,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,107849000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2015-01-01,2015-12-31,c195,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,-124280000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2015-01-01,2015-12-31,c2014,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,1036000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2015-01-01,2015-12-31,c355,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,-124280000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2015-01-01,2015-12-31,c433,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,-124280000.0,,-80771000.0,21905000.0,92157000.0,3289000.0,608000.0,993992000.0,262616000.0,259327000.0,498320000.0,79.5,2673000.0,22795000.0,10294000.0,14.3,166171000.0,0.0,781000.0,53209000.0,756407.0,-19.3,142000.0,36000.0,26391000.0,63539000.0,384956000.0,87314000.0,37296000.0,-186480000.0,-223628000.0,3334000.0,498320000.0,37148.0,-5.3,-3.5,1160163000.0,7338000.0,-62200000.0,-62200000.0,453686000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2015-12-31,2015-12-31,c1294,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,385000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2015-12-31,2015-12-31,c1369,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2015-12-31,2015-12-31,c406,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2015-12-31,2015-12-31,c408,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,129754000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2015-12-31,2015-12-31,c418,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2015-12-31,2015-12-31,c5,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",3489061000.0,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,129754000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8644000.0,4391086000.0,11092000.0,390000.0,214888000.0,4612000.0,1310075000.0,8644000.0,1867108000.0,3078000.0,4391086000.0,772271000.0,4176198000.0,128581000.0,67300000.0,4167554000.0,987293000.0,129754000.0,3488671000.0,772271000.0,479515000.0,203796000.0,35646000.0,15467000.0,96238000.0,148708000.0,,,,,,,,,,,,,
26060702,2016-01-01,2016-01-01,c136,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,23924000.0,32568000.0,,,,,,,,,,,
26060702,2016-01-01,2016-01-01,c2,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,129754000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2016-01-01,2016-01-01,c217,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,550497000.0,2417605000.0,,,,,,,,,
26060702,2016-01-01,2016-01-01,c235,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,489601000.0,1799676000.0,,,,,,,,,
26060702,2016-01-01,2016-01-01,c242,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6428000.0,9506000.0,,,,,,,,,
26060702,2016-01-01,2016-01-01,c246,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,987293000.0,,,,,,,,,
26060702,2016-01-01,2016-01-01,c312,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",390000.0,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2016-01-01,2016-01-01,c351,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",3488671000.0,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2016-01-01,2016-12-31,c1,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,109185000.0,,0.0,33280000.0,88694000.0,5114000.0,596000.0,1046972000.0,292982000.0,275736000.0,492644000.0,76.1,818000.0,7864000.0,184000.0,17.9,228344000.0,12132000.0,2090000.0,0.0,193078.0,12.0,2943000.0,9000.0,13715000.0,193000.0,11642000.0,24947000.0,37200000.0,139433000.0,152955000.0,3032000.0,492644000.0,-13522.0,3.4,3.1,1275316000.0,7163000.0,30248000.0,30248000.0,448281000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2016-01-01,2016-12-31,c105,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,state authorised public accountant,Rikke Lund-KÃ¼hl,,,,,,,
26060702,2016-01-01,2016-12-31,c106,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,1086000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,state authorised public accountant,Torben Jensen,,,,,,,
26060702,2016-01-01,2016-12-31,c137,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,5114000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2016-01-01,2016-12-31,c194,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,109185000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2016-01-01,2016-12-31,c222,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,113749000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.0,0.0,423917000.0,-80000.0,,
26060702,2016-01-01,2016-12-31,c236,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,160002000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,14706000.0,-2573000.0,653632000.0,-82000.0,,
26060702,2016-01-01,2016-12-31,c243,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,1985000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.0,0.0,1248000.0,0.0,,
26060702,2016-01-01,2016-12-31,c247,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,193078000.0,0.0,0.0,-1089391000.0,0.0,,
26060702,2016-01-01,2016-12-31,c33,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Inga Birgitte Thygesen,
26060702,2016-01-01,2016-12-31,c352,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,109185000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2016-01-01,2016-12-31,c435,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,141254.0,,,,,,552.0,,,,,88.9,,,,22.2,,,,,417653.0,13.9,,,,,,,,,160276.0,,,22503.0,4.1,4.0,1153760.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2016-01-01,2016-12-31,c438,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,102686.0,,,,,,483.0,,,,,91.8,,,,20.3,,,,,165635.0,12.9,,,,,,,,,135606.0,,,-6889.0,3.6,2.9,1054130.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2016-01-01,2016-12-31,c441,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,49803.0,,,,,,375.0,,,,,93.3,,,,22.1,,,,,193567.0,10.0,,,,,,,,,65857.0,,,620.0,1.7,1.4,660824.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2016-01-01,2016-12-31,c49,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Allan Frank Fischer Petersen,
26060702,2016-01-01,2016-12-31,c50,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Lars Petersen,
26060702,2016-01-01,2016-12-31,c76,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2016-12-31,2016-12-31,c1368,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-227000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2016-12-31,2016-12-31,c138,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12798000.0,,,,,,,,,,,,,,,,,,,28876000.0,41674000.0,,,,,,,,,,,
26060702,2016-12-31,2016-12-31,c223,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2177196000.0,,,,,,,,,,,,,664326000.0,2841522000.0,,,,,,,,,
26060702,2016-12-31,2016-12-31,c237,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1791490000.0,,,,,,,,,,,,,647112000.0,2438602000.0,,,,,,,,,
26060702,2016-12-31,2016-12-31,c244,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2341000.0,,,,,,,,,,,,,8413000.0,10754000.0,,,,,,,,,
26060702,2016-12-31,2016-12-31,c248,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90980000.0,,,,,,,,,,,,,0.0,90980000.0,,,,,,,,,
26060702,2016-12-31,2016-12-31,c314,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",390000.0,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2016-12-31,2016-12-31,c353,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",3597856000.0,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2016-12-31,2016-12-31,c405,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2815000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2016-12-31,2016-12-31,c407,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,195914000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2016-12-31,2016-12-31,c417,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-35468000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2016-12-31,2016-12-31,c437,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",3613340.0,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4066767.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2016-12-31,2016-12-31,c440,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",3472087.0,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3784036.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2016-12-31,2016-12-31,c443,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",3512401.0,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3763370.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26060702,2016-12-31,2016-12-31,c7,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",3598246000.0,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,163034000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12798000.0,4730794000.0,21160000.0,390000.0,655989000.0,3141000.0,1791490000.0,12798000.0,2177196000.0,2341000.0,4730794000.0,969514000.0,4074805000.0,155726000.0,0.0,4062007000.0,90980000.0,163034000.0,3597856000.0,969514000.0,693923000.0,634829000.0,631688000.0,15467000.0,0.0,104398000.0,,,,,,,,,,,,,
26060702,2016-12-31,2016-12-31,c72,,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzA2L2U4L2Y1LzAwLzI0YzEtNDAwNC1hMTc4LTcyMGU4MTFjNTUyZA.pdf,http://regnskaber.virk.dk/20706062/ZG9rdW1lbnRsYWdlcjovLzAzLzExL2Y1L2M4LzgxL2Y5MGUtNDcyZC1iYjVkLTgyMWQ3Y2FmMDNmZQ.xml,Danmark,Hellerup,2900.0,44.0,Strandvejen,HillerÃ¸d,3400.0,1.0,Biogen AllÃ©,"Postboks 250, 2000 Frederiksberg",Osvald Helmuths Vej 4,To the shareholders of Biogen (Denmark) Manufacturing ApS,"Regnskabsklasse C, stor virksomhed",The annual report is prepared in accordance with the Danish Financial Statements Act.,"In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Company's operations for the financial year 1 January - 31 December 2016.",2017-05-29,2017-05-29,2001-06-01,2017-05-29,None.,None.,"Administrative expenses include expenses incurred in the year for company management and administration, including expenses relating to administrative staff, Management, office premises and expenses as well as amortisation/depreciation of assets used for administrative purposes.",Cash comprise cash and short term securities which are readily convertible into cash and subject only to minor risks of changes in value.,"Prepayments recognised under ""Assets"" comprise prepaid expenses regarding subsequent financial reporting years.","Financial income and expenses are recognised in the income statement at the amounts that relate to the reporting period. Net financials include interest income and expenses, realised and unrealised capital and exchange gains and losses on foreign currency transactions  and surcharges and allowances under the advance-payment-of-tax scheme, etc.","Financial ratios are calculated in accordance with the Danish Finance Society's recommendations on the calculation of financial ratios ""Recommendations and Financial Ratios 2015"". For terms and definitions, please see the accounting policies.",Other liabilities are measured at net realisable value.,"Other operating income and operating expenses comprise items of a secondary nature relative to the Company's core activities, including gains or losses on the sale of non-current assets.","We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditorâs Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.","Since the end of the financial year and until this date, there have been no events, which materially change the presentation of the annual report.","The provision for deferred tax primarily relates to timing differences in respect of intangible assets, property, plant and equipment, provisions and tax loss.","Amortisation/depreciation of intangible assets and property, plant and equipment are recognised in the income statement under the following items, Production costs with t.kr. 264,981 and Administrative expenses with t.kr. 15,870.","Other operating expenses include tax adjustment and losses on the sale of property, plant and equipment, including other operating equipment.","Tax adjustments, prior years includes tax refunds received/paid between jointly taxed entities.",,"With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement has been prepared. The entity's cash flows are part of the consolidated cash flow statement for the parent company Biogen Inc.","Prepayments include accrual of expenses relating to subsequent financial years, including rent and accrued Pharmaceutical Operations & Technology expenses.",77416070.0,www.biogen.dk,33771231.0,26060702.0,30700228.0,"Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Biogen (Denmark) Manufacturing ApS for the financial year 1 January - 31 December 2016.",9106000.0,"By reference to section 98b(3), (ii), of the Danish Financial Statements Act, remuneration to Management is not disclosed.",The annual report of Biogen (Denmark) Manufacturing ApS for 2016 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to large reporting class C entities.,Segment information is given for revenue broken down by geographical segment. The segmentation is in accordance with the entity's internal financial management.,Ãrsrapport,"Further, in our opinion, the Management's review gives a fair review of the development in the Company's operations and financial matters and the results of the Company's operations and financial position.",Muna Yahaya,Lars Petersen,PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab,Biogen (Denmark) Manufacturing ApS,Ernst & Young Godkendt Revisionspartnerselskab,"Copenhagen,",2015-01-01,2015-12-31,We recommend that the annual report be approved at the annual general meeting.,HillerÃ¸d,2016-12-31,2016-01-01,The Company's share capital  has remained DKK 390 thousand over the past 5 years.,2017-05-29,"Copenhagen,",+45 39 45 39 45,77416000.0,Chairman,-162000.0,RevisionspÃ¥tegning,urn:ofk:oid:24071936,indberetninger-20180424,2.5124211,26060702.0,,2018-03-28T21:28:19.582Z,2017-06-02T01:55:36.979Z,regnskab,0.0,,2016-12-31,2016-01-01,X17-AL-14-VZ,2017-06-02T01:55:37.220Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,385000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,A
